Richard Duke
Directeur Général chez MenoGenix, Inc.
Profil
Richard C.
Duke was the founder of GlobeImmune, Inc. where he served as President & Chief Executive Officer from 1995 to 2013.
He is also the founder of ApopLogic Pharmaceuticals, Inc., and Colorado Institute For Drug Device & Diagnostic Development.
Currently, he is the Chairman & Chief Executive Officer of MenoGenix, Inc. and an Associate Professor at The University of Colorado.
Previously, he served as Chairman & Chief Executive Officer of Peptivir, Inc. and as a Director at Sierra Neuropharmaceuticals, Inc. Dr. Duke received his undergraduate degree from McGill University in 1978, his graduate degree from McGill University in 1981, and his doctorate from The University of Colorado in 1985.
Postes actifs de Richard Duke
| Sociétés | Poste | Début |
|---|---|---|
| The University of Colorado | Corporate Officer/Principal | - |
ApopLogic Pharmaceuticals, Inc.
 ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO. | Directeur Général | 01/01/2006 |
MenoGenix, Inc.
 MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Directeur Général | - |
Anciens postes connus de Richard Duke
| Sociétés | Poste | Fin |
|---|---|---|
Colorado Institute For Drug Device & Diagnostic Development
 Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Fondateur | - |
Sierra Neuropharmaceuticals, Inc.
 Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Directeur/Membre du Conseil | - |
Peptivir, Inc.
 Peptivir, Inc. Pharmaceuticals: MajorHealth Technology PeptiVir, Inc. operates as a biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases. The company is headquartered in Aurora, CO. | Directeur Général | - |
| GLOBEIMMUNE, INC. | Fondateur | - |
Formation de Richard Duke
| McGill University | Undergraduate Degree |
| The University of Colorado | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GLOBEIMMUNE, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Health Technology |
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO. | Health Technology |
Peptivir, Inc.
Peptivir, Inc. Pharmaceuticals: MajorHealth Technology PeptiVir, Inc. operates as a biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases. The company is headquartered in Aurora, CO. | Health Technology |
MenoGenix, Inc.
MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Health Technology |
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Health Services |
